These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 14742323

  • 1. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
    Calvisi DF, Ladu S, Factor VM, Thorgeirsson SS.
    Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
    [Abstract] [Full Text] [Related]

  • 2. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF, Factor VM, Loi R, Thorgeirsson SS.
    Cancer Res; 2001 Mar 01; 61(5):2085-91. PubMed ID: 11280770
    [Abstract] [Full Text] [Related]

  • 3. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 4. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1996 Aug 01; 149(2):407-28. PubMed ID: 8701981
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS, Arsura M.
    Mol Cancer Res; 2005 Jul 01; 3(7):403-12. PubMed ID: 16046551
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
    Loeppen S, Schneider D, Gaunitz F, Gebhardt R, Kurek R, Buchmann A, Schwarz M.
    Cancer Res; 2002 Oct 15; 62(20):5685-8. PubMed ID: 12384525
    [Abstract] [Full Text] [Related]

  • 7. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
    Aydinlik H, Nguyen TD, Moennikes O, Buchmann A, Schwarz M.
    Oncogene; 2001 Nov 22; 20(53):7812-6. PubMed ID: 11753661
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
    Calvisi DF, Thorgeirsson SS.
    Toxicol Pathol; 2005 Nov 22; 33(1):181-4. PubMed ID: 15805070
    [Abstract] [Full Text] [Related]

  • 9. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes HP, Schirmacher P.
    J Pathol; 2003 Oct 22; 201(2):250-9. PubMed ID: 14517842
    [Abstract] [Full Text] [Related]

  • 10. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun 22; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

  • 11. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB.
    Oncogene; 1996 Aug 15; 13(4):757-65. PubMed ID: 8761297
    [Abstract] [Full Text] [Related]

  • 12. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
    Calvisi DF, Conner EA, Ladu S, Lemmer ER, Factor VM, Thorgeirsson SS.
    J Hepatol; 2005 Jun 15; 42(6):842-9. PubMed ID: 15885355
    [Abstract] [Full Text] [Related]

  • 13. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W.
    Oncogene; 2002 Jul 18; 21(31):4863-71. PubMed ID: 12101426
    [Abstract] [Full Text] [Related]

  • 14. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
    Wu Y, Renard CA, Apiou F, Huerre M, Tiollais P, Dutrillaux B, Buendia MA.
    Oncogene; 2002 Feb 28; 21(10):1518-26. PubMed ID: 11896580
    [Abstract] [Full Text] [Related]

  • 15. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
    Christensen JG, Goldsworthy TL, Cattley RC.
    Mol Carcinog; 1999 Aug 28; 25(4):273-84. PubMed ID: 10449034
    [Abstract] [Full Text] [Related]

  • 16. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
    Factor VM, Jensen MR, Thorgeirsson SS.
    Hepatology; 1997 Dec 28; 26(6):1434-43. PubMed ID: 9397983
    [Abstract] [Full Text] [Related]

  • 17. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
    Yang F, Zeng Q, Yu G, Li S, Wang CY.
    Cell Signal; 2006 May 28; 18(5):679-87. PubMed ID: 16084063
    [Abstract] [Full Text] [Related]

  • 18. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L, Terradillos O, Calvo L, Costabile B, Cicchini C, Della Rocca C, Lozupone F, Piacentini M, Buendia MA, Tripodi M.
    Oncogene; 2002 Feb 21; 21(9):1335-45. PubMed ID: 11857077
    [Abstract] [Full Text] [Related]

  • 19. A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors.
    Loeppen S, Koehle C, Buchmann A, Schwarz M.
    Carcinogenesis; 2005 Jan 21; 26(1):239-48. PubMed ID: 15471898
    [Abstract] [Full Text] [Related]

  • 20. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H, Stephens LC, Kumar R.
    Clin Cancer Res; 2006 Mar 01; 12(5):1479-86. PubMed ID: 16533771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.